Perineal Massage in Women With Gynecological Cancer

University of Alcala35 enrolled

Overview

The high incidence of gynecological cancers, together with dyspareunia and vaginal stenosis, some of its most frequent sequelae, create the need to continue studying and researching oncological physiotherapy techniques that treat and prevent these sequelae, in order to preserve and/or improve the quality of life of cancer patients. Therefore, through this study, we sought to verify the effectiveness of oncological perineal massage to treat pain during sexual intercourse and vaginal stenosis. The objective of this study will be to demonstrate the effectiveness of a treatment that will consist of a health education session related to the pelvic floor and the consequences related to cancer along with ten sessions of oncological perineal massage that will be carried out for fifty minutes, once a week.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Cancer Pain Neck Cancer

Interventions

The technique will be applied for approximately twenty minutes and will be carried out as follows: the vaginal dilator is introduced progressively using crescent-shaped movements. Once the dilator is fully inserted, movements will be made from bottom to top and from one side to the other, and then continue with the crescent-shaped movements.

Standard treatmentOTHER

The treatment will consist of the use of vaginal dilators according to the gold standard proposed in the literature. It will consist of introducing the same dilators as for the experimental group, with the same time schedule, but without massage, only introducing the dilator and keeping it in the vagina for 20 minutes.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 52 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women between 18 and 52 years old * Oncology patients with a diagnosis of dyspareunia and vaginal stenosis related to treatments. * Patients with QT/RT/BT treatment who have a diagnosis of dyspareunia and vaginal stenosis. * Patients on hormonal suppressive treatment with a diagnosis of dyspareunia and vaginal stenosis. Exclusion Criteria: * Patients who do not accept intracavitary treatment. * Patients with abdominopelvic surgical treatment prior to oncological process. * Patients with a diagnosis of dyspareunia prior to cancer. * Patients with vaginal narrowing prior to cancer. * Patients with menopause at the time of cancer diagnosis

Outcomes

Primary Outcomes

Pain (Visual Analoge Scale)

Visual Analogical Scale (VAS) is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured orientated from the left "0" (worst) to the right "10"(best)